Study on the Clinical Efficacy of Bailing Tablets Combined with Strengthening the Spleen and Kidney in the Treatment of Nephropathy

To observe and study the clinical efficacy of Bailing tablets combined with method strengthening spleen, benefiting kidney, removing turbidity blood stasis in treatment patients gouty nephropathy, to provide a reliable theoretical basis basis. A total 120 primary nephropathy diagnosed our hospital from December 2018 2020 were divided into intervention group control (randomized). The was treated alone, while stasis. Clinical efficacy, syndrome renal function, urine protein, immune status, psychological etc., compared between two groups after treatment. significantly improved overall response rate (93.3 % vs. 81.6 %, p<0.05), post-treatment creatinine (127.1±23.1) μmol/l (140.3±37.3) (p<0.05). cluster differentiation 4/cluster 8 (1.23±0.17), which lower than that (1.89±0.18) Adverse effects generally similar (p>0.05). using is clinically important for improving reducing occurrence adverse systemic immunity, safe effective drug nephropathy.